This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Mareke Hartig: Innovator in Respiratory Pharmaceutical Formulations
Introduction
Mareke Hartig is a distinguished inventor based in Ingelheim, Germany. She has made significant contributions to the field of respiratory medicine through her innovative formulations. With a total of 2 patents, her work focuses on improving treatments for chronic respiratory conditions.
Latest Patents
Mareke's latest patents include two notable inventions. The first is an "Encapsulated tiotropium containing powder formulation for inhalation." This invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them, and their use in creating a pharmaceutical composition for treating respiratory complaints, particularly COPD (chronic obstructive pulmonary disease) and asthma. The second patent is titled "Tiotropium containing powder formulation for inhalation," which shares similar objectives and applications in the treatment of respiratory issues.
Career Highlights
Mareke Hartig is currently employed at Boehringer Ingelheim Pharma GmbH & Co. KG, where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the efficacy of inhalation therapies for patients suffering from chronic respiratory diseases.
Collaborations
Mareke collaborates with several talented professionals in her field, including Michael Trunk and Michael Walz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Mareke Hartig's contributions to respiratory pharmaceutical formulations highlight her dedication to improving patient care. Her innovative patents and collaborative efforts position her as a key figure in the advancement of treatments for respiratory conditions.